Variant report

Variant	nsv876632
Chromosome Location	chr3:25325479-25366205
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:103)
CpG islands
(count:185)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:103 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr3:25347645-25347845	HepG2	liver:	n/a	n/a
2	CEBPB	chr3:25335270-25335500	Hela-S3	cervix:	n/a	n/a
3	CTCF	chr3:25339300-25339450	HMEC	breast:	n/a	n/a
4	CTCF	chr3:25339320-25339470	AG09319	gingival:	n/a	n/a
5	CTCF	chr3:25339320-25339470	AG04449	skin:	n/a	n/a
6	CTCF	chr3:25339340-25339490	HCPEpiC	choroid plexus:	n/a	n/a
7	CTCF	chr3:25339300-25339450	SAEC	small airway:	n/a	n/a
8	CTCF	chr3:25339320-25339470	HCPEpiC	choroid plexus:	n/a	n/a
9	CTCF	chr3:25352880-25353030	HFF-Myc	foreskin:	n/a	n/a
10	CTCF	chr3:25346525-25346664	H1-hESC	embryonic stem cell:	n/a	chr3:25346600-25346613
11	CTCF	chr3:25346471-25346741	H1-hESC	embryonic stem cell:	n/a	chr3:25346600-25346613
12	CTCF	chr3:25339260-25339410	HEEpiC	esophagus:	n/a	n/a
13	CTCF	chr3:25339300-25339450	HMF	breast:	n/a	n/a
14	CTCF	chr3:25339360-25339510	HCFaa	heart:	n/a	n/a
15	CTCF	chr3:25339280-25339430	HAc	cerebellar:	n/a	n/a
16	CTCF	chr3:25339400-25339550	BJ	skin:	n/a	n/a
17	CTCF	chr3:25339240-25339390	HMF	breast:	n/a	n/a
18	CTCF	chr3:25339280-25339430	AG09319	gingival:	n/a	n/a
19	CTCF	chr3:25339220-25339370	MCF-7	breast:	n/a	n/a
20	CTCF	chr3:25346480-25346630	A549	lung:	n/a	chr3:25346600-25346613
21	E2F4	chr3:25354892-25355081	MCF10A-Er-Src	breast:	n/a	n/a
22	FOS	chr3:25339325-25339656	MCF10A-Er-Src	breast:	n/a	n/a
23	FOS	chr3:25334124-25334569	MCF10A-Er-Src	breast:	n/a	n/a
24	FOS	chr3:25358250-25358383	MCF10A-Er-Src	breast:	n/a	n/a
25	FOS	chr3:25335244-25335590	MCF10A-Er-Src	breast:	n/a	n/a
26	FOS	chr3:25334133-25334464	MCF10A-Er-Src	breast:	n/a	n/a
27	FOS	chr3:25325852-25326052	MCF10A-Er-Src	breast:	n/a	n/a
28	FOS	chr3:25325853-25326160	MCF10A-Er-Src	breast:	n/a	n/a
29	FOS	chr3:25339329-25339633	MCF10A-Er-Src	breast:	n/a	n/a
30	FOS	chr3:25339309-25339661	MCF10A-Er-Src	breast:	n/a	n/a
31	FOS	chr3:25335269-25335556	MCF10A-Er-Src	breast:	n/a	n/a
32	FOS	chr3:25339320-25339655	MCF10A-Er-Src	breast:	n/a	n/a
33	FOS	chr3:25334196-25334491	MCF10A-Er-Src	breast:	n/a	n/a
34	FOS	chr3:25343451-25343651	MCF10A-Er-Src	breast:	n/a	n/a
35	FOS	chr3:25335286-25335543	MCF10A-Er-Src	breast:	n/a	n/a
36	FOS	chr3:25325807-25326061	MCF10A-Er-Src	breast:	n/a	n/a
37	FOS	chr3:25343522-25343688	MCF10A-Er-Src	breast:	n/a	n/a
38	FOS	chr3:25335245-25335588	MCF10A-Er-Src	breast:	n/a	n/a
39	FOSL2	chr3:25325707-25326218	A549	lung:	n/a	n/a
40	FOXA2	chr3:25339322-25339580	A549	lung:	n/a	n/a
41	GATA3	chr3:25349111-25349313	SH-SY5Y	brain:	n/a	n/a
42	GATA3	chr3:25335159-25335376	T-47D	breast:	n/a	n/a
43	JUN	chr3:25358773-25358898	K562	blood:	n/a	n/a
44	JUND	chr3:25339415-25339607	H1-hESC	embryonic stem cell:	n/a	n/a
45	MAFK	chr3:25339040-25339275	HepG2	liver:	n/a	n/a
46	MAFK	chr3:25334361-25334551	HepG2	liver:	n/a	chr3:25334425-25334445 chr3:25334428-25334442
47	MAFK	chr3:25353574-25353597	Hela-S3	cervix:	n/a	n/a
48	MYC	chr3:25335189-25335564	MCF10A-Er-Src	breast:	n/a	n/a
49	MYC	chr3:25335244-25335612	MCF10A-Er-Src	breast:	n/a	n/a
50	MYC	chr3:25339347-25339649	MCF10A-Er-Src	breast:	n/a	n/a

(count:185 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:25329845-25329895	PrEC	prostate:	n/a
2	chr3:25329845-25329895	GM06990	blood:	n/a
3	chr3:25329845-25329895	PrEC	prostate:	n/a
4	chr3:25329845-25329895	GM06990	blood:	n/a
5	chr3:25365560-25365610	Hela-S3	cervix:	n/a
6	chr3:25347174-25347224	HRCEpiC	kidney:	n/a
7	chr3:25329845-25329895	NHBE	bronchial:	n/a
8	chr3:25347174-25347224	AG09309	skin:	n/a
9	chr3:25365560-25365610	Jurkat	blood:	n/a
10	chr3:25347174-25347224	NT2-D1	testis:	n/a
11	chr3:25329845-25329895	HepG2	liver:	n/a
12	chr3:25347174-25347224	T-47D	breast:	n/a
13	chr3:25329845-25329895	U87	brain:	n/a
14	chr3:25347174-25347224	HCF	heart:	n/a
15	chr3:25365560-25365610	BJ	skin:	n/a
16	chr3:25365560-25365610	AG10803	skin:	n/a
17	chr3:25365560-25365610	PrEC	prostate:	n/a
18	chr3:25329845-25329895	HRPEpiC	eye:	n/a
19	chr3:25365560-25365610	HRCEpiC	kidney:	n/a
20	chr3:25365560-25365610	HepG2	liver:	n/a
21	chr3:25329845-25329895	Caco-2	colon:	n/a
22	chr3:25365560-25365610	SAEC	small airway:	n/a
23	chr3:25365560-25365610	GM12878	blood:	n/a
24	chr3:25365560-25365610	A549	lung:	n/a
25	chr3:25365560-25365610	AG04450	lung:	fetal
26	chr3:25365560-25365610	HPAEpiC	pulmonary alveolar:	n/a
27	chr3:25329845-25329895	NH-A	brain:	n/a
28	chr3:25347174-25347224	GM06990	blood:	n/a
29	chr3:25329845-25329895	AoSMC	blood vessel:	n/a
30	chr3:25347174-25347224	Jurkat	blood:	n/a
31	chr3:25347174-25347224	SK-N-SH_RA	brain:	n/a
32	chr3:25347174-25347224	HUVEC	blood vessel:	n/a
33	chr3:25365560-25365610	K562	blood:	n/a
34	chr3:25347174-25347224	HNPCEpiC	eye:	n/a
35	chr3:25347174-25347224	Hepatocyte	liver:	n/a
36	chr3:25365560-25365610	LNCaP	prostate:	n/a
37	chr3:25347174-25347224	HL-60	blood:	n/a
38	chr3:25347174-25347224	GM12878	blood:	n/a
39	chr3:25365560-25365610	HL-60	blood:	n/a
40	chr3:25347174-25347224	SK-N-SH	brain:	n/a
41	chr3:25329845-25329895	HNPCEpiC	eye:	n/a
42	chr3:25347174-25347224	NHBE	bronchial:	n/a
43	chr3:25365560-25365610	HRE	kidney:	n/a
44	chr3:25365560-25365610	IMR90	lung:	fetal
45	chr3:25329845-25329895	CMK	blood:	n/a
46	chr3:25329845-25329895	H1-hESC	embryonic stem cell:	embryo
47	chr3:25329845-25329895	K562	blood:	n/a
48	chr3:25329845-25329895	HAEpiC	amniotic membrane:	n/a
49	chr3:25347174-25347224	AoSMC	blood vessel:	n/a
50	chr3:25329845-25329895	MCF10A-Er-Src	breast:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr3:25336192..25339070-chr3:25343250..25345381,3	MCF-7	breast:
2	chr3:25336192..25339070-chr3:25343250..25345381,3	MCF-7	breast:

No data

Variant related genes	Relation type
CFL1P7	TF binding region
CFL1P7	CpG island

Extended variants
information (count: 1325 )
Associated
traits (count: 73 )

Variant overlapped rSNPs/rCNVs (count:1325 , 50 per page) page: 1 2 3 4 5 6 7 ... 27

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1436239	chr3:25325479-25325480	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs140878788	chr3:25325504-25325505	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs368924064	chr3:25325514-25325515	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs545114589	chr3:25325551-25325552	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs543748996	chr3:25325579-25325580	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs141930485	chr3:25325600-25325601	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs533370184	chr3:25325612-25325613	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs113979984	chr3:25325636-25325637	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs575746993	chr3:25325699-25325700	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs146303518	chr3:25325748-25325749	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs541508227	chr3:25325884-25325885	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs561481611	chr3:25325918-25325919	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs530350108	chr3:25325927-25325928	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs115840496	chr3:25325932-25325933	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs145022732	chr3:25325955-25325956	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs71061206	chr3:25325958-25325959	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs563870952	chr3:25325986-25325987	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs532828946	chr3:25326057-25326058	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs577041834	chr3:25326065-25326066	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs13069258	chr3:25326083-25326084	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs571197378	chr3:25326131-25326132	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs148575979	chr3:25326147-25326148	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs192066625	chr3:25326149-25326150	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs184205392	chr3:25326175-25326176	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs547126730	chr3:25326185-25326186	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs567001853	chr3:25326196-25326197	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs559273347	chr3:25326199-25326200	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs536089443	chr3:25326229-25326230	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs374549597	chr3:25326251-25326252	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs556314888	chr3:25326284-25326285	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs368477099	chr3:25326285-25326286	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs142006212	chr3:25326302-25326303	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs150699715	chr3:25326312-25326313	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs139862037	chr3:25326331-25326332	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs528236599	chr3:25326364-25326365	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs533518769	chr3:25326365-25326366	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs371981947	chr3:25326366-25326367	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs190011330	chr3:25326368-25326369	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs547380191	chr3:25326414-25326415	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs144838036	chr3:25326419-25326420	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs544733291	chr3:25326451-25326452	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs147581231	chr3:25326479-25326480	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs543692437	chr3:25326508-25326509	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs181187873	chr3:25326523-25326524	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs547836631	chr3:25326534-25326535	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs56062751	chr3:25326535-25326536	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs546444750	chr3:25326573-25326574	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs78923339	chr3:25326609-25326610	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs376345020	chr3:25326622-25326623	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs527318287	chr3:25326654-25326655	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:73)

Disease	PMID	Source
Esophageal squamous carcinoma	18405350	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Neuroblastoma	17327916	CNVD
Glioblastoma multiforme	21080181	CNVD
Neuroblastoma	18923191	CNVD
Colorectal cancer	21297112	CNVD
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
lymphocytic leukemia	21291569	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Intellectual disability	22102821	CNVD
Esophageal cancer	20955586	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Squamous cell cancer	20885788	CNVD
Breast cancer	17133270	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Melanoma	20688739	CNVD
Myelofibrosis	22110671	CNVD
Multiple myeloma	17550852	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:182 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:25323400-25333600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr3:25324800-25329800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
3	chr3:25325000-25325600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
4	chr3:25325000-25325600	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
5	chr3:25325600-25326400	Enhancers	Aorta	Aorta
6	chr3:25325600-25329200	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
7	chr3:25328400-25336800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
8	chr3:25328600-25336200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
9	chr3:25328800-25329000	Enhancers	HUES48 Cell Line	embryonic stem cell
10	chr3:25329000-25329400	Enhancers	ES-I3 Cell Line	embryonic stem cell
11	chr3:25329000-25330600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
12	chr3:25329000-25332800	Weak transcription	HUES48 Cell Line	embryonic stem cell
13	chr3:25329200-25336200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
14	chr3:25329400-25329800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
15	chr3:25329600-25330800	Enhancers	HUES64 Cell Line	embryonic stem cell
16	chr3:25329600-25331000	Enhancers	H1 Cell Line	embryonic stem cell
17	chr3:25329600-25331000	Enhancers	iPS-20b Cell Line	embryonic stem cell
18	chr3:25329600-25331200	Enhancers	iPS-18 Cell Line	embryonic stem cell
19	chr3:25329800-25330600	Enhancers	ES-I3 Cell Line	embryonic stem cell
20	chr3:25329800-25330600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
21	chr3:25329800-25330600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
22	chr3:25329800-25330600	Enhancers	HUES6 Cell Line	embryonic stem cell
23	chr3:25329800-25330800	Enhancers	H9 Cell Line	embryonic stem cell
24	chr3:25330000-25330600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr3:25330000-25330800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
26	chr3:25330200-25331200	Enhancers	Fetal Stomach	stomach
27	chr3:25330400-25330600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
28	chr3:25330400-25331200	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
29	chr3:25330600-25332000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
30	chr3:25330600-25332000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
31	chr3:25330600-25333400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
32	chr3:25330600-25333600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
33	chr3:25330600-25334600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
34	chr3:25330600-25334600	Weak transcription	HUES6 Cell Line	embryonic stem cell
35	chr3:25330600-25334600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
36	chr3:25330800-25331000	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
37	chr3:25330800-25332000	Weak transcription	HUES64 Cell Line	embryonic stem cell
38	chr3:25330800-25335200	Weak transcription	H9 Cell Line	embryonic stem cell
39	chr3:25331000-25333200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
40	chr3:25331200-25331600	Weak transcription	Fetal Stomach	stomach
41	chr3:25331200-25332600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
42	chr3:25331600-25335600	Enhancers	Fetal Stomach	stomach
43	chr3:25332000-25332600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
44	chr3:25332000-25335800	Enhancers	HUES64 Cell Line	embryonic stem cell
45	chr3:25332000-25336400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
46	chr3:25332200-25332400	Enhancers	Placenta	Placenta
47	chr3:25332400-25334000	Enhancers	Fetal Kidney	kidney
48	chr3:25332600-25333600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
49	chr3:25332600-25333600	Enhancers	Cortex derived primary cultured neurospheres	brain
50	chr3:25332600-25333600	Enhancers	Brain Germinal Matrix	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links